Back to News
Market Impact: 0.3
Takeda Pharmaceutical Company Limited Reports JPY 2,406,997 Million Revenue for the Six-Month Period Ended September 30, 2026
Source: Nasdaq
Corporate EarningsHealthcare & BiotechCompany Fundamentals
Takeda reported six-month revenue of JPY 2,406,997 million for the period ended September 30, 2026, up from JPY 2,219,481 million a year earlier. Net profit was reported at JPY 305,716 million; the available article text provides no prior-year comparison or further results details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
TAK0.65
More News
- DoorDash offers $17 billion for Instacart: ‘the largest companies are only eating more and more of the pie’
- Alphabet Erases $500 Billion as ChatGPT, Google AI Cut into Search
- Norwegian shares surge 13% on earnings beat, guidance raise
- Alphabet’s stock has worst day in over 20 years, dragging the S&P 500 to first loss in four days
- Taiwan Stocks Heads for Correction as Global AI Selloff Deepens
- Asia stocks tumble as AI spending concerns deepen; BOJ holds rates